Imodium Multi-Symptom Relief Caplets Recalled for Defective Containers
McNeil Consumer Healthcare is recalling Imodium Multi-Symptom Relief Caplets due to defective containers and damaged blister units.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences, fitting the 'Low' severity criteria for packaging-only problems.
Plain-English summary
McNeil Consumer Healthcare, Division of McNeil-PPC, Inc., is recalling Imodium Multi-Symptom Relief Caplets (Loperamide HCl 2 mg/Simethicone 125 mg) in 18-count blister pack cartons. The recall involves 53,892 packages distributed nationwide. The specific lot number is CMF023 with an expiration date of 07/13.
The recall was initiated because of defective containers and damaged blister units. The U.S. Food and Drug Administration has classified this as a Class III recall, indicating that the defect is unlikely to cause adverse health consequences.
Consumers with this product should stop using it and contact the manufacturer for instructions on how to return the product or obtain a refund.
The recalled product
- Product
- Imodium Multi-Symptom Relief Caplets, Loperamide HCl 2 mg/Simethicone 125 mg, 18 count blister pack cartons, McNeil Consumer Healthcare, Div of McNeil-PPC Inc., Fort Washington, PA
- Hazard
- Affected units
- 53,892
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #CMF023
- Expiration 07/13.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Mcneil Consumer Healthcare, Div Of Mcneil-ppc, Inc.
See all →- HighInfant ibuprofen drops are recalled nationwide for process-related particulates
FDA (Drugs) · 2013-10-23
Same hazard · packaging defect
See all →- HighEmbosphere Microspheres Recalled Due to Packaging Sterility Concerns
FDA (Devices) · 2026-10-07
- ModerateAmneal Recalls Estradiol Gel Packets Due to Empty or Partially Full Containers
FDA (Drugs) · 2026-10-07
- HighCardinal Health Recalls Presource Convenience Kits Due to Seal Defects
FDA (Devices) · 2026-09-30
- ModerateAVID Medical Recalls Halyard IV Start Kits Due to Packaging Seal Issues
FDA (Devices) · 2026-09-30
- HighCardinal Health Recalls Presource Convenience Kits Due to Potential Seal Defects
FDA (Devices) · 2026-09-30
Similar recalls
- ModerateRemedyRepack Recalls Rocuronium Bromide Vials Due to Incorrect Storage Instructions
FDA (Drugs) · 2015-12-16
- LowMutual Pharmaceutical Recalls Imipramine HCl Tablets Due to Chemical Contamination
FDA (Drugs) · 2015-09-16
- ModerateHikma Recalls Irinotecan Hydrochloride Vials Due to Container Defect
FDA (Drugs) · 2020-06-24
- ModerateClindamycin HCl 300 mg Capsule Recalled for CGMP Deviations
FDA (Drugs) · 2025-04-30
- SevereCustomceutical Compounding Recalls Lipoplex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
- SevereAidapak Recalls Clomipramine Capsules Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22